Skip to main content
OpenTrials

Clinical trial condition

Virus Diseases

Explore clinical trials studying Virus Diseases. Study availability and eligibility vary by location and protocol.

18,936 public trials 1,286 recruiting studies
Refine in advanced search Browse all conditions

Virus Diseases trial results

Active, Not Recruiting

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

NCT05011123

Conditions
Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +7 more
Locations
  • Investigational Site Number : 2460001 Helsinki, Finland
  • Investigational Site Number : 2460002 Tampere, Finland
  • Investigational Site Number : 2460003 Turku, Finland
  • Investigational Site Number : 2500008 Lyon, France
View all 23 locations
View Trial Details
Active, Not Recruiting

DMID 23-0015; Lassa Fever CVD 1000

NCT06546709

Conditions
Arenaviridae Infections, Hemorrhagic Fevers, Viral, Infections, +3 more
Locations
  • University of Maryland, Baltimore, University of Maryland School of Medicine, Center for Vaccine Development and Global Health Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

NCT03036930

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia

NCT02879695

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
Locations
  • Yale University New Haven, Connecticut, United States
  • University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions